XTL BIOPHARMACEUTICALS ANNOUNCES THE RESULTS OF THE OFFERING ON THE TEL-AVIV STOCK EXCHANGE OF ITS ORDINARY SHARES AND WARRANTS TO PURCHASE ITS ORDINARY SHARES